CE Holdings (4320) Q3 2026 earnings summary

Executive summary

• Revenue and all profit stages increased year-over-year, driven by large-scale EMR system deployments despite a reduction in consolidated scope from changes in equity-method affiliates.

• Net sales for the nine months ended June 30, 2026, rose 7.9% year-over-year to ¥13,292 million, with operating profit up 14.1% to ¥1,364 million and ordinary profit up 14.9% to ¥1,384 million.

• Profit attributable to owners of parent increased 4.6% year-over-year to ¥685 million, while earnings per share were ¥41.14, slightly down from ¥42.37 in the prior year.

• Operating and ordinary profit rose due to higher EMR sales, offsetting impairment losses from new smartphone services.

Financial highlights

• Revenue for Q3 FY2026 was ¥13,292 million, up 7.9% year-over-year.

• Operating profit reached ¥1,364 million, a 14.1% increase year-over-year.

• Ordinary profit was ¥1,384 million, up 14.9% year-over-year.

• Net profit attributable to parent was ¥685 million, up 4.6% year-over-year, despite impairment losses.

• Gross profit increased to ¥3,026 million from ¥2,795 million year-over-year, with gross margin improvement.

Outlook and guidance

• No changes to full-year earnings forecast since the March 30, 2026 announcement.

• FY2026 revenue projected at ¥16,000 million (+8.2% YoY), operating profit at ¥1,600 million (+11.5% YoY), and net profit at ¥870 million (+16.5% YoY).

• Full-year net sales forecasted at ¥16,000 million, up 1.1% year-over-year.

• Operating and ordinary profit both projected at ¥1,600 million, up 13.3% and 12.1% respectively.

• Profit attributable to owners of parent expected to decline 44.2% to ¥870 million, with EPS forecasted at ¥52.21.

• Year-end dividend forecast revised to zero due to planned privatization; no interim or year-end dividends planned.

• Risks of sales decline and margin compression in Q4 and beyond due to prolonged procurement and rising costs.